The requirement to disclose the list price of prescription drugs in advertisements aims to reduce prices paid by consumers. Stacie Dusetzina, PhD, associate professor in the Department of Health Policy explains to NBC News why disclosing drug prices might not result in lower costs to patients.

Bloomberg reports that while antibiotics are essential to many clinical treatments, pharmaceutical producers are growing more reluctant to produce them due in part to declining revenue potential.

  Dr. Bill Schaffner, MD, a professor of preventive medicine and infectious disease expert, explains to Consumer Reports why it's important to get a measles vaccine or booster. The U.S. was experiencing the worst outbreak of measles in nearly two decades.

In this April 29, 2019, article from Reuters Health, Stacie Dusetzina, PhD, associate professor in the Department of Health Policy, explains why rising drug prices for neurological conditions like epilepsy and multiple sclerosis can create potentially riskier situations for patients and higher rates of emergency department use for hospitals. 

By Joan Brasher and Jill Clendening   Experts from Vanderbilt University School of Medicine’s Department of Health Policy and Vanderbilt University’s Peabody College of Education and Human Development are joining efforts to establish a Policies for Action (P4A) Research Hub at Vanderbilt to better understand and develop recommendations to address the needs of some of Tennessee’s most vulnerable children, including children in immigrant families and children with prenatal exposure to opioids.